Evidence map›Paper›PMID 37312076›Full record

ArticleBMC psychiatry2023

The quality of mental health care for people with bipolar disorders in the Italian mental health system: the QUADIM project.

Barbara D'Avanzo, Angelo Barbato, Matteo Monzio Compagnoni, Giulia Caggiu, Liliana Allevi, Flavia Carle, Teresa Di Fiandra, Lucia Ferrara, Andrea Gaddini, Michele Sanza and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Barbara D'AvanzoDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
Angelo BarbatoDepartment of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
Matteo Monzio CompagnoniNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy. matteo.monziocompagnoni@unimib.it.
Giulia CaggiuNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Liliana AlleviDepartment of Mental Health and Addiction Services, ASST Lecco, Lecco, Italy.
Flavia CarleNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Teresa Di FiandraNational Institute of Health, Rome, Italy.
Lucia FerraraCentre of Research on Health and Social Care Management, SDA Bocconi School of Management (Bocconi University, Milan, Italy.
Andrea GaddiniAgency for Public Health, Lazio Region, Rome, Italy.
Michele SanzaDepartment of Mental Health and Substance Abuse, Local Health Trust of Romagna, Cesena, Italy.
Alessio SaponaroGeneral Directorate of Health and Social Policies, Emilia-Romagna Region, Bologna, Italy.
Salvatore ScondottoNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Valeria D TozziCentre of Research on Health and Social Care Management, SDA Bocconi School of Management (Bocconi University, Milan, Italy.
Cristina GiordaniDepartment of Health Planning, Italian Health Ministry, Rome, Italy.
Giovanni CorraoNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Antonio LoraNational Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
University of Milano-Bicocca · ITAziende Socio Sanitarie Territoriali di LeccoBocconi University · ITMario Negri Institute for Pharmacological Research · ITAgenzia Regionale per la Protezione Ambientale del Piemonte · ITAgenzia Sanitaria e Sociale Regionale · ITAzienda Unità Sanitaria Locale Della Romagna · ITMinistero della Salute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assessment of the quality of care pathways delivered to people with severe mental disorders in a community-based system remains uncommon, especially using healthcare utilization databases. The aim of the study was to evaluate the quality of care provided to people with bipolar disorders taken-in-care by mental health services of four Italian areas (Lombardy, Emilia-Romagna, Lazio, province of Palermo).

methodsThirty-six quality indicators were implemented to assess quality of mental health care for patients with bipolar disorders, according to three dimensions (accessibility and appropriateness, continuity, and safety). Data were retrieved from healthcare utilization (HCU) databases, which contain data on mental health treatments, hospital admissions, outpatient interventions, laboratory tests and drug prescriptions.

results29,242 prevalent and 752 incident cases taken-in-care by regional mental health services with a diagnosis of bipolar disorder in 2015 were identified. Age-standardized treated prevalence rate was 16.2 (per 10,000 adult residents) and treated incidence rate 1.3. In the year of evaluation, 97% of prevalent cases had ≥ 1 outpatient/day-care contacts and 88% had ≥ 1 psychiatric visits. The median of outpatient/day-care contacts was 9.3 interventions per-year. Psychoeducation was provided to 3.5% of patients and psychotherapy to 11.5%, with low intensity. 63% prevalent cases were treated with antipsychotics, 71.5% with mood stabilizers, 46.6% with antidepressants. Appropriate laboratory tests were conducted in less than one-third of prevalent patients with a prescription of antipsychotics; three quarters of those with a prescription of lithium. Lower proportions were observed for incident patients. In prevalent patients, the Standardized Mortality Ratio was 1.35 (95% CI: 1.26-1.44): 1.18 (1.07-1.29) in females, 1.60 (1.45-1.77) in males. Heterogeneity across areas was considerable in both cohorts.

conclusionsWe found a meaningful treatment gap in bipolar disorders in Italian mental health services, suggesting that the fact they are entirely community-based does not assure sufficient coverage by itself. Continuity of contacts was sufficient, but intensity of care was low, suggesting the risk of suboptimal treatment and low effectiveness. Care pathways were monitored and evaluated using administrative healthcare databases, adding evidence that such data may contribute to assess the quality of clinical pathways in mental health.

Indexed as

Antipsychotic AgentsBipolar DisorderMental Health ServicesAdultFemaleHumansLithiumMaleMental HealthAntipsychotic AgentsLithiumBipolar disordersClinical pathwaysHealthcare researchHealthcare servicesHealthcare utilization databasesMental health carePublic healthQuality of mental health careReal-worldTreatment gap

Identifiers

PMID37312076
PMCPMC10261835
OpenAlexW4380577478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.